Cure8 research brief
Identifies a redox-sensitive NOX1–ROS–IκBζ pathway that may sustain intestinal inflammation in IBD and points to a new molecular target for future therapies.
Researchers, translational scientists, and clinicians interested in IBD pathogenesis and therapeutic targets.
The paper reports that NOX1 (an epithelial NADPH oxidase) and the atypical NF-κB regulator IκBζ are both increased in colonic tissue and organoids from people with IBD.
In lab models, blocking NOX1 reduced IκBζ induction by inflammatory stimuli, and reactive oxygen species oxidized IκBζ at a specific cysteine residue, preventing its degradation and prolonging inflammatory gene expression. Organoid transcriptomics pointed to downstream inflammatory genes (for example CCL2) controlled by this axis.
The authors propose the NOX1–ROS–IκBζ axis as a potential therapeutic target in IBD.
Laboratory and organoid findings suggest a mechanism but do not establish effectiveness or safety of targeting NOX1/IκBζ in patients; clinical relevance will require further preclinical and clinical studies.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of Competing Interest ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
If true, a common gut microbe (Fusobacterium nucleatum) and its metabolite succinic acid could worsen intestinal inflammation by changing macrophage behavior, suggesting new targets to reduce flares or mucosal injury in...
The study identifies a specific protein interaction that may underlie persistent inflammation; for people with Crohn’s and other inflammatory conditions this points to a potential new, more targeted treatment approach in...
The study links a gut microbe (F. nucleatum) and its metabolite succinic acid to inflammatory activation of intestinal macrophages—an immune mechanism that can worsen colitis. Understanding this pathway could point...
